Organization | University of Tampa

University of Tampa Report issue

Academic/Hospital

Organization Overview

First Clinical Trial

2012

NCT01508338

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2013

Timeline

NOW

Now

Active Ingredients

Drugs in Other Trials (3)

adenosine 5'-triphosphate disodium salt (1 trial)

beta-hydroxyisovaleric acid (1 trial)

triphosphoric acid adenosine ester (2 trials)

Indications

Overview

Highest Phase: Phase 0
# of Trials: 2
# of Trial APIs: 3